DoJ Takes Action On Insys For 'Unfair, Deceptive Marketing Practices' Of Fentanyl Drug

By: via Benzinga
Insys Therapeutics Inc (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company whose product Subsys is a sublingual ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.